The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening

Inclusion Criteria: * Female adult participants in general good health as determined from a recent medical history. * Participants in the age group of 20-45 years (both ages inclusive). * Participants having Fitzpatrick photo-type III-V. * Participants with at least 3 spots on the cheek either of PIH post acne/age related * Participants not presenting any skin condition that may interfere with the assessment for the entire study duration. * Participants free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face * Participant who agrees not to use any other product/treatment/home remedy/serum on their face during the study period other than the study product. * Participants who agree to remove all jewellery on/around face (e.g., necklace, earrings, nose ring), during imaging. * Participants willing to give a voluntary written informed consent and photography release. * Participants willing to abide by and comply with the study protocol. * Participants able to read, understand and sign an appropriate informed consent form indicating her willingness to participate. * Participants willing and capable to follow the study rules and a fixed schedule. Exclusion Criteria: * Participants who are currently participating in a similar study or have participated in a similar study in the past 6 weeks. * Participants with any other signs of significant local irritation, erythema, or skin disease on skin. * Participants having chronic illness or who have undergone major surgery in the last year that may be clinically relevant or can impact the results as determined by the dermatologist. * Participants undergoing treatment for any skin condition. * Participants allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else. * Participants with self-perceived pimple prone and/or sensitive skin. * Participants taking any oral antibiotic medication currently or within the last 8 weeks. * Participants taking medication continuously/regularly every day such as corticosteroids or non-steroidal anti-inflammatories, topically for four weeks or orally for eight weeks prior to the study. * Female participant pregnant/breast feeding or planning pregnancy during the study period (self-declared) * Participants taking product/treatment for any condition which the Investigator believes may influence the interpretation of the data. * Participants currently taking any medication, which the investigator believes may influence the interpretation of the data.